Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection

Detalhes bibliográficos
Autor(a) principal: Corrêa-Oliveira,R.
Data de Publicação: 1998
Outros Autores: Malaquias,L.C.C., Falcão,P.L., Viana,I.R.C., Bahia-Oliveira,L.M.G., Silveira,A.M.S., Fraga,L.A.O., Prata,A., Coffman,R.L., Lambertucci,J.R., Cunha-Melo,J.R., Martins-Filho,O.A., Wilson,R.A., Gazzinelli,G.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000100024
Resumo: The role of different cytokines in the peripheral blood mononuclear cell (PBMC) proliferative response and in in vitro granuloma formation was evaluated in a cross-sectional study with patients with the different clinical forms and phases of Schistosoma mansoni infection, as well as a group of individuals "naturally" resistant to infection named normal endemic (NE). The blockage of IL-4 and IL-5 using anti-IL-4 and anti-IL-5 antibodies significantly reduced the PBMC proliferative response to soluble egg (SEA) and adult worm (SWAP) antigens in acute (ACT), chronic intestinal (INT) and hepatosplenic (HS) patients. Similar results were obtained in the in vitro granuloma formation. Blockage of IL-10 had no significant effect on either assay using PBMC from ACT or HS. In contrast, the addition of anti-IL-10 antibodies to PBMC cultures from INT patients significantly increased the proliferative response to SEA and SWAP as well as the in vitro granuloma formation. Interestingly, association of anti-IL-4 and anti-IL-10 antibodies did not increase the PBMC proliferative response of these patients, suggesting that IL-10 may act by modulating IL-4 and IL-5 secretion. Addition of recombinant IL-10 decreased the proliferative response to undetectable levels when PBMC from patients with the different clinical forms were used. Analysis of IFN-<FONT FACE="Symbol">g</font> in the supernatants showed that PBMC from INT patients secreted low levels of IFN-<FONT FACE="Symbol">g</font> upon antigenic stimulation. In contrast, PBMC from NE secreted high levels of IFN-<FONT FACE="Symbol">g</font>. These data suggest that IL-10 is an important cytokine in regulating the immune response and possibly controlling morbidity in human schistosomiasis mansoni, and that the production of IFN-<FONT FACE="Symbol">g</font> may be associated with resistance to infection.
id ABDC-1_463973b50cf15dd22aa07c6c0aaf4c14
oai_identifier_str oai:scielo:S0100-879X1998000100024
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infectionSchistosoma mansonihuman schistosomiasis mansonicytokinesIL-10IL-4IFN-<FONT FACE=Symbol>g</font>The role of different cytokines in the peripheral blood mononuclear cell (PBMC) proliferative response and in in vitro granuloma formation was evaluated in a cross-sectional study with patients with the different clinical forms and phases of Schistosoma mansoni infection, as well as a group of individuals "naturally" resistant to infection named normal endemic (NE). The blockage of IL-4 and IL-5 using anti-IL-4 and anti-IL-5 antibodies significantly reduced the PBMC proliferative response to soluble egg (SEA) and adult worm (SWAP) antigens in acute (ACT), chronic intestinal (INT) and hepatosplenic (HS) patients. Similar results were obtained in the in vitro granuloma formation. Blockage of IL-10 had no significant effect on either assay using PBMC from ACT or HS. In contrast, the addition of anti-IL-10 antibodies to PBMC cultures from INT patients significantly increased the proliferative response to SEA and SWAP as well as the in vitro granuloma formation. Interestingly, association of anti-IL-4 and anti-IL-10 antibodies did not increase the PBMC proliferative response of these patients, suggesting that IL-10 may act by modulating IL-4 and IL-5 secretion. Addition of recombinant IL-10 decreased the proliferative response to undetectable levels when PBMC from patients with the different clinical forms were used. Analysis of IFN-<FONT FACE="Symbol">g</font> in the supernatants showed that PBMC from INT patients secreted low levels of IFN-<FONT FACE="Symbol">g</font> upon antigenic stimulation. In contrast, PBMC from NE secreted high levels of IFN-<FONT FACE="Symbol">g</font>. These data suggest that IL-10 is an important cytokine in regulating the immune response and possibly controlling morbidity in human schistosomiasis mansoni, and that the production of IFN-<FONT FACE="Symbol">g</font> may be associated with resistance to infection.Associação Brasileira de Divulgação Científica1998-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000100024Brazilian Journal of Medical and Biological Research v.31 n.1 1998reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/S0100-879X1998000100024info:eu-repo/semantics/openAccessCorrêa-Oliveira,R.Malaquias,L.C.C.Falcão,P.L.Viana,I.R.C.Bahia-Oliveira,L.M.G.Silveira,A.M.S.Fraga,L.A.O.Prata,A.Coffman,R.L.Lambertucci,J.R.Cunha-Melo,J.R.Martins-Filho,O.A.Wilson,R.A.Gazzinelli,G.eng1998-10-07T00:00:00Zoai:scielo:S0100-879X1998000100024Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:1998-10-07T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection
title Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection
spellingShingle Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection
Corrêa-Oliveira,R.
Schistosoma mansoni
human schistosomiasis mansoni
cytokines
IL-10
IL-4
IFN-<FONT FACE=Symbol>g</font>
title_short Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection
title_full Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection
title_fullStr Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection
title_full_unstemmed Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection
title_sort Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection
author Corrêa-Oliveira,R.
author_facet Corrêa-Oliveira,R.
Malaquias,L.C.C.
Falcão,P.L.
Viana,I.R.C.
Bahia-Oliveira,L.M.G.
Silveira,A.M.S.
Fraga,L.A.O.
Prata,A.
Coffman,R.L.
Lambertucci,J.R.
Cunha-Melo,J.R.
Martins-Filho,O.A.
Wilson,R.A.
Gazzinelli,G.
author_role author
author2 Malaquias,L.C.C.
Falcão,P.L.
Viana,I.R.C.
Bahia-Oliveira,L.M.G.
Silveira,A.M.S.
Fraga,L.A.O.
Prata,A.
Coffman,R.L.
Lambertucci,J.R.
Cunha-Melo,J.R.
Martins-Filho,O.A.
Wilson,R.A.
Gazzinelli,G.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Corrêa-Oliveira,R.
Malaquias,L.C.C.
Falcão,P.L.
Viana,I.R.C.
Bahia-Oliveira,L.M.G.
Silveira,A.M.S.
Fraga,L.A.O.
Prata,A.
Coffman,R.L.
Lambertucci,J.R.
Cunha-Melo,J.R.
Martins-Filho,O.A.
Wilson,R.A.
Gazzinelli,G.
dc.subject.por.fl_str_mv Schistosoma mansoni
human schistosomiasis mansoni
cytokines
IL-10
IL-4
IFN-<FONT FACE=Symbol>g</font>
topic Schistosoma mansoni
human schistosomiasis mansoni
cytokines
IL-10
IL-4
IFN-<FONT FACE=Symbol>g</font>
description The role of different cytokines in the peripheral blood mononuclear cell (PBMC) proliferative response and in in vitro granuloma formation was evaluated in a cross-sectional study with patients with the different clinical forms and phases of Schistosoma mansoni infection, as well as a group of individuals "naturally" resistant to infection named normal endemic (NE). The blockage of IL-4 and IL-5 using anti-IL-4 and anti-IL-5 antibodies significantly reduced the PBMC proliferative response to soluble egg (SEA) and adult worm (SWAP) antigens in acute (ACT), chronic intestinal (INT) and hepatosplenic (HS) patients. Similar results were obtained in the in vitro granuloma formation. Blockage of IL-10 had no significant effect on either assay using PBMC from ACT or HS. In contrast, the addition of anti-IL-10 antibodies to PBMC cultures from INT patients significantly increased the proliferative response to SEA and SWAP as well as the in vitro granuloma formation. Interestingly, association of anti-IL-4 and anti-IL-10 antibodies did not increase the PBMC proliferative response of these patients, suggesting that IL-10 may act by modulating IL-4 and IL-5 secretion. Addition of recombinant IL-10 decreased the proliferative response to undetectable levels when PBMC from patients with the different clinical forms were used. Analysis of IFN-<FONT FACE="Symbol">g</font> in the supernatants showed that PBMC from INT patients secreted low levels of IFN-<FONT FACE="Symbol">g</font> upon antigenic stimulation. In contrast, PBMC from NE secreted high levels of IFN-<FONT FACE="Symbol">g</font>. These data suggest that IL-10 is an important cytokine in regulating the immune response and possibly controlling morbidity in human schistosomiasis mansoni, and that the production of IFN-<FONT FACE="Symbol">g</font> may be associated with resistance to infection.
publishDate 1998
dc.date.none.fl_str_mv 1998-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000100024
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000100024
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-879X1998000100024
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.31 n.1 1998
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302929172430848